Centre Ramps Up Production Capacity Of Remdesivir Injections Up To 74 Lakh Vials

"The production capacity is being ramped up from current level of 38 lakh vials per month to 74 lakh vials per month, and 20 additional manufacturing sites have been approved," the ministry said.

Amid reports of shortage of antiviral drug Remdesivir, the centre on Wednesday announced that the production capacity of Remdesivir injections is being ramped up from the current level of 38 lakh vials per month to 74 lakh vials per month. It also said that 20 additional manufacturing sites have been approved. The Union health ministry in coordination with the Department of Pharmaceuticals has made an interim allocation of Remdesivir for 19 states and Union territories (UTs) for the period up to April 30, to further address reports of shortage of the drug in certain regions of the country and facilitate its smooth inter-state supply. "Remdesivir being an investigational therapy drug given in acute and severe versions of COVID-19 where oxygen support is a must, this allocation pertains to 14 states/UTs, including Delhi, Chhattisgarh, Maharashtra and Gujarat, to which medical oxygen is allocated, and five other states where high volume of supplies is being observed," the ministry said in a statement.